Comparison of DEB with Conventional TACE in the Management of HCC

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Comparison of DEB with Conventional TACE in the Management of HCC

By SYNERGY FEATURING Daniel Brown

912 views

March 25, 2015

Synergy 2015 - November 5-8, 2015 http://synergymiami.org/

Comments 0

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Colorectal Cancer Webinar

Thu, Mar 27, 2025

See 1 other

Yale Cancer Center

Gastroesophageal Cancer Webinar

Thu, Apr 24, 2025

Total Health

Best of ASCO GI Cancer

Sat, Apr 5, 2025

Multidisciplinary Approach to Hepatocellular Carcinoma

UCLA Health

G. Choi, B. Yanny, S. Sadeghi, J. Hui

477 views

Early HCC: Surveillance and Diagnosis

The France Foundation

V. Ajmera

101 views

Updates in Hepatocellular Carcinoma

Michigan Medicine

N. Razumilava

192 views

ESMO 2024 Summary: Highlights in HCC

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

289 views

Resection, Ablation, and the Emerging Role of Immunotherapy in Early…

The France Foundation

A. Burgoyne

93 views

Choosing the Best HCC Treatment Based on Patient and Disease Stage

Integrity CE

M. Pishvaian, R. Finn, R. Salem, A. Singal

218 views

Management of Hepatocellular Carcinoma

8th Annual Liver Conference

A. Singal

161 views

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views

ESMO 2024 Summary: Updates in HCC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

H. Babiker

224 views

Treatment Approaches in Early-Stage HCC: An Overview of Curative Tre…

The France Foundation

A. Burgoyne

74 views

Impact of Neoadjuvant IO on Recurrence-Free Survival in High-Risk Lo…

Johns Hopkins

M. Nakazawa

146 views

New

ASCO® GI 2025 Summary: Intermediate HCC and the Management of Liver …

Insights from 2025 ASCO® GI Annual Meeting

M. Reig

53 views

New

ASCO® GI 2025 Summary: Key Trial Highlights in Hepatobiliary Cancer …

Insights from 2025 ASCO® GI Annual Meeting

R. Kim, T. Biachi

70 views

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

412 views

Expert Panel on Sequencing Treatments in HCC

Integrity CE

M. Pishvaian, R. Finn, A. Singal, R. Salem

92 views

ESMO 2024 Summary: Optimizing Curative Opportunities in Early HCC

2024 ESMO Annual Meeting Insights Hub

S. L. Chan

115 views

Hepatocellular Carcinoma: Current Management Strategies

Stanford Medicine

R. Dhanasekaran

251 views

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

5.4K views

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Yale Cancer Center

A. Jaffe

344 views

New

Liver Transplant and the Emerging Role of Immunotherapy in Early-Sta…

The France Foundation

V. Ajmera

12 views

AUTOPLAY

Login

Login

Join VuMedi

Comparison of DEB with Conventional TACE in the Management of HCC

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Related Videos

Colorectal Cancer Webinar

Gastroesophageal Cancer Webinar

Best of ASCO GI Cancer

Multidisciplinary Approach to Hepatocellular Carcinoma

Early HCC: Surveillance and Diagnosis

Updates in Hepatocellular Carcinoma

ESMO 2024 Summary: Highlights in HCC

Resection, Ablation, and the Emerging Role of Immunotherapy in Early…

Choosing the Best HCC Treatment Based on Patient and Disease Stage

Management of Hepatocellular Carcinoma

Hyperprogression in Cancer Treated With Immunotherapy

ESMO 2024 Summary: Updates in HCC and Impacts on Practice

Treatment Approaches in Early-Stage HCC: An Overview of Curative Tre…

Impact of Neoadjuvant IO on Recurrence-Free Survival in High-Risk Lo…

ASCO® GI 2025 Summary: Intermediate HCC and the Management of Liver …

ASCO® GI 2025 Summary: Key Trial Highlights in Hepatobiliary Cancer …

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

Expert Panel on Sequencing Treatments in HCC

ESMO 2024 Summary: Optimizing Curative Opportunities in Early HCC

Hepatocellular Carcinoma: Current Management Strategies

Vogl,NY on How to Ask Good Questions at Medical Meetings

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Liver Transplant and the Emerging Role of Immunotherapy in Early-Sta…